Correction: Mesothelin Overexpression Is a Marker of Tumor Aggressiveness and Is Associated with Reduced Recurrence-Free and Overall Survival in Early-Stage Lung Adenocarcinoma

In this article (Clin Cancer Res 2014;20:1020–8), which was published in the February 15, 2014, issue of Clinical Cancer Research (1), the grant support is listed incorrectly. It should read as follows: “P. Adusumilli and M. Sadelain are supported by a Stand Up To Cancer—Cancer Research Institute Cancer Immunology Translational Cancer Research Grant (SU2C-AACR-DT1012). Stand Up To Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research.” The publisher regrets this error.